JG
ROIVW

Jefferies Group’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Jefferies Group’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,077
Closed -$8.87K – 1943
2022
Q1 		$8.87K Sell
10,077
-40,123
-80% -$51K ﹤0.01% 1471
2021
Q4 		$103K Buy
+50,200
New +$76.6K ﹤0.01% 1473

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Jefferies Group's ROIVW Position: Q2 2022 in Review

Jefferies Group sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q2 2022, closing a stake of 10,077 shares — an estimated $8.87K sold.

Jefferies Group first reported a position in ROIVW in Q4 2021 and held it in 2 quarters. The position peaked at $103K in Q4 2021. 31 funds tracked by Wall St. Rank hold ROIVW as of Q2 2022.

  • Jefferies Group reported no remaining Roivant Sciences Ltd. Warrant position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 10,077 Roivant Sciences Ltd. Warrant shares in Q2 2022, an estimated $8.87K.
  • Jefferies Group first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 2 quarters.
  • Jefferies Group's Roivant Sciences Ltd. Warrant position peaked at $103K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.